Menu
Recruiting NCT06791733

The Effects of Inter-set Stretching on Muscle Performance

No phase Interventional Healthy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Passive static stretching.
Who it may be relevant to
Registry conditions: Healthy. Basic parameters: from 18 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Static passive muscle stretching, performed weekly, can increase muscle flexibility and range of motion. Typically, static stretching is performed either before starting specific exercises or at the end of a workout. However, the effects of static passive stretching when performed during sets are still not entirely clear in terms of performance. This study aims to evaluate the effects of inter-set stretching on muscle performance

Detailed description

This project aims to evaluate the potential effects of stretching exercises on muscular performance. In particular, we aim to administer passive static stretching between sets of a bench press performance. Within this project we will carry out a crossover design project in which the participants will be tested for two conditions and one control session. The main protocol consists of performing five sets of bench press at 70% of 1-RM. The 1-RM will be calculated before the start of the data collection procedure, through a standardized and validated approach. The experimental sessions will comprise two interventions. The first intervention will be to administer the stretching protocol to the agonist muscles involved in the bench press performance (pectoralis muscles). While the second intervention will be to administer the stretching protocol to the antagonist muscles involved in the bench press performance (dorsal muscles). Within the control session the participants will not perform any stretching between sets. The three arms will be randomized. As outcome variables, the primary outcome will be the comparison of the total volume across each agonist, antagonist, and control session. The secondary outcomes to be assessed are strength, power, velocity, and volume.

Interventions

  • Other Passive static stretching
    the intervention consists of passive static stretching of agonist or antagonist muscles between sets

Primary outcome measures

  • Muscular performance [Time frame: From enrollment to the end of a treatment at 2 weeks]
Secondary outcome measures (3)
  • Strength [Time frame: From enrollment to the end of a treatment at 2 weeks]
  • Power [Time frame: From enrollment to the end of a treatment at 2 weeks]
  • Velocity [Time frame: From enrollment to the end of a treatment at 2 weeks]

Eligibility criteria

Inclusion criteria

  • Healthy men aged ≥ 18 years.
  • At least 6-month experience of resistance training.
  • No previous musculoskeletal injuries in the 6 months prior to the study will be recruited

Exclusion criteria

  • Participants who suffered an injury within the 6 months prior to the study and/or participants with pathological conditions affecting the musculoskeletal system will not be recruited.
  • Female participants
  • Participants with less than 18 years.
  • Participants who match all inclusion criteria but who fail to attend one or more of the agonist/antagonist stretching sessions will be also excluded.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Other

Study locations

Italy · 2 centers
  • University of Palermo — Palermo
  • University of Palermo — Palermo

Identifiers

NCT: NCT06791733 · 150/2023 · University of Palermo

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗